cv 6209 has been researched along with interleukin-8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aosaki, N; Minezaki, K; Nakamura, H; Nakazawa, H; Ohsuzu, F; Senoh, M; Tuji, C | 1 |
Fietzner, K; Fink, L; Grimminger, F; Hattar, K; Himmel, B; Seeger, W; Sibelius, U | 1 |
2 other study(ies) available for cv 6209 and interleukin-8
Article | Year |
---|---|
Early release of neutrophil chemotactic factor from isolated rat heart subjected to regional ischaemia followed by reperfusion.
Topics: Animals; Chemotaxis; Disease Models, Animal; Hot Temperature; Interleukin-8; Isoquinolines; Male; Myocardial Reperfusion Injury; Myocardium; Phenylpropionates; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Tetrahydroisoquinolines; Time Factors | 1993 |
Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
Topics: Arachidonate 5-Lipoxygenase; Cells, Cultured; Culture Media, Conditioned; Cyclooxygenase Inhibitors; Dinoprostone; Down-Regulation; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Platelet Activating Factor; Pyridinium Compounds; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Solubility; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |